Today in the New York Times, an issue comes to light regarding the scarcity of cancer drugs, not just for the elderly but for unfortunate children as well.  The  letter below speaks for this.

 submitted  Sunday, August 07th, 2011 at 6:47 am.
Name: Julian Lieb,M.D


Donald Berwick, M.D
Centers for Medicare & Medicaid Services, 
7500 Security Boulevard, 
Baltimore MD 21244-1850 

Dear Dr. Berwick,
It is the ethical and human right of every patient, physician, and citizen 
within your sphere of influence, to receive this information, and as soon as 
possible .No one may review, suppress, modify, or otherwise corrupt it. I assume 
that you will diffuse it, as soon as possible, through every means of 
communication available to you. Please notify me once that process is underway.
Thank you.
Julian Lieb, M.D

Semi-retired, former Yale medical school professor, widely published
25 years ago, I initiated a series of communications regarding a remarkable 
innovation for infectious disorders to various operatives of Medicare. In 2001, 
I added an equally remarkable innovation for cancer. During this period, I twice 
approached Dr Berwick at his prior position. Thousands of vested interests have 
purged the innovations, inflicting colossal human and financial colossal damage 
on society, and substantially bloating the deficit. When I wrote recently to Dr 
Berwick, I knew that issue involved ethics; only later realizing that it also 
refers to article 19 of the declaration of human rights, written in 1946 in the 
hope of preventing such atrocities as took place during the Second World War. 
I wrote to a panel of Medicare physicians only a few weeks ago, with similar 
results. The relationship of Dr Berwick to the Harvard medical school is a 
matter of grave concern, and of Harvard’s influence on politicians, government 
healthy policy, and on lay and media. I have similar concerns relating to 
Harvard’s relationship with the New England Journal of Medicine, and the 
Massachusetts Medical Society,
The Booth Institute of Economics has assessed a cancer “cure”  at  $50 trillion 
for the U.S alone, and the innovation is as close to a cure as we are likely to 
see for a very long time. For Berwick/Medicare to inflict cut backs on the care 
of elders, and on their physicians under these circumstances, is unethical, 
unjust and diabolical. It is my ethical duty, and professional responsibility, 
to make these concerns public. 
Julian Lieb, M.D
Isn't it time that we used our resources more wisely and addressed this matter?
What are your suggestions?